Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5-and 35-based vectors

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Barratt-Boyes, S. M.
  • Soloff, A. C.
  • Gao, W. T.
  • Nwanegbo, E.
  • Liu, X. D.
  • Rajakumar, P. A.
  • Brown, K. N.
  • Robbins, Paul D.
  • Murphey-Corb, M.
  • Day, R. D.
  • Gambotto, A.

publication date

  • January 2006

journal

  • Journal of General Virology  Journal

abstract

  • Adenovirus serotype 35 (Ad35) is a promising vaccine platform for human immunodeficiency virus (HIV) infection and emerging infectious diseases as it is uncommon in humans worldwide and is distinct from Ad5, the major vaccine serotype for which many individuals have pre-existing immunity. The immunogenicity of a first-generation, replication-competent Ad35-based vaccine was tested in the simian immunodeficiency virus (SIV) rhesus macaque model by evaluating its capacity to boost immunity generated by Ad5-based vectors. A series of four immunizations with replication-defective Ad5 vectors expressing SIVmac239 gag induced high-frequency responses mediated by both CD8(+) and CD4(+) T cells directed against several epitopes. Ad5-specific neutralizing antibody responses that did not neutralize Ad35 were rapidly induced but waned over time. Subsequent immunization with Ad5-based vectors was minimally effective, whereas immunization with Ad35-based vectors generated a strong increase in the frequency of Gag-specific T cells with specificities that were unchanged. While this boosting response was relatively transient, challenge with the distinct pathogenic isolate SIV/DeltaB670 generated robust and selective recall responses to Gag with similar specificities as induced by vaccination that were elevated for 25 weeks relative to controls. Vaccination had measurable albeit minor effects on virus load. Unexpectedly, regional hypervariability within the Gag sequence of SIV/DeltaB670 was associated with mutation of the conserved CD8(+) T-cell epitope CM9 without concurrent flanking mutations and in the absence of immune pressure. These findings support the further development of Ad35 as a vaccine vector, and promote vaccine regimens that utilize serial administration of heterologous adenoviruses.

subject areas

  • Adenoviruses, Human
  • Animals
  • Antibody Formation
  • CD8-Positive T-Lymphocytes
  • Gene Products, gag
  • Genetic Vectors
  • Immunity, Cellular
  • Immunization, Secondary
  • Macaca mulatta
  • Simian Immunodeficiency Virus
  • Vaccines, Synthetic
  • Viral Vaccines
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0022-1317

Digital Object Identifier (DOI)

  • 10.1099/vir.0.8.1445-0

PubMed ID

  • 16361426
scroll to property group menus

Additional Document Info

start page

  • 139

end page

  • 149

volume

  • 87

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support